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AbstractIndividual-based model (IBM) has been used to simulate and to design control strategies for dynamic systems that are subject to stochasticity and heterogeneity, such as infectious diseases. In the IBM, an individual 
is represented by a set of specific characteristics that may change dynamically over time. This feature allows a more realistic analysis of the spread of an epidemic. This paper presents a literature survey of IBM applied to biomedical and epidemiology research. The main goal is to present existing techniques, advantages and future perspectives in the development of the model. We evaluated 89 articles, which mostly analyze interventions aimed at endemic infections. In addition to the review, an overview of IBM is presented as an alternative to complement or replace compartmental models, such as the SIR (Susceptible-Infected-Recovered) model. Numerical simulations also illustrate the capabilities of IBM, as well as some limitations regarding the effects of discretization. We show that similar side-effects of discretization scheme for compartmental models may also occur in IBM, which requires careful attention.
Keywords: Individual-based model; Epidemiology; Infectious diseases; Biomedical research.
IntroductionFor centuries, humanity has been marked by adversity in the pursuit of survival. Wars, famine, the climate beyond predators are some of main challenges for humanity’s progress and survival. However, no other factor brings so much fear to society as epidemics [1]. The black death 
of the fourteenth century and the influenza pandemic that occurred during First World War were responsible for at least 100 million deaths 
[2,3]. Nowadays, acquired immune deficiency syndrome (AIDS) has 
been universally recognized by its significant impact on mortality rates, especially in developing countries, threatening global health. In 2016, an 
estimated 36.7 million people were living with AIDS [4], were 19.4 million 
are in East and Southern Africa. This is an example of the disastrous effect 
of infectious diseases. Although the application of public health polices has controlled some main epidemic threats, particularly in developing 
countries, policies to limit their occurrence have been insufficient [5,6]. The course of the epidemic is determined by the social aspects and the initiatives implemented to contain it.Therefore, understanding the epidemiological process and the pathogenesis of diseases has became increasingly relevant [7]. The study of the dynamics of infectious diseases, as well as methods that may support the development of strategies for prevention and control 
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of diseases through mathematical models, have been widely developed. Mathematical models provide a powerful toolkit in the process to control and prevent the emergence, expansion or resurgence of pathogens, since the availability of options requires continuous evaluation using different 
methods. Also known as mathematical epidemiology, this 
tool is one of the most important scientific activities to help in the eradication of diseases [8].
Among many mathematical modeling strategies, one of the most studied is the compartmental technique, such as the SIR model (Susceptible-Infected-Recovered) [9]. The SIR model has been applied in many areas [10]. Using a time series SIR model, the authors in [11] have found that the initial phase 
of the epidemic is stochastic. Stone et al. [12] and Aron and Schwartz [13] obtained period-doubling bifurcation 
and chaos in epidemic models. Nowak et al. [14] indicated that mathematical models are used for understanding 
phenomena like AIDS pathogenesis. There are many papers that apply control theory in several compartmental models. In general, in the theory of epidemic dynamical models there are continuous-time models described by differential equations, and the discrete-time models described by difference equations. However, differential (difference) equations are not adequate to model a system in which 
the individuals present important differences [15]. This behavior is due to the fragility of compartmental models assuming that the distribution of individuals is spatially and temporally homogeneous. Therefore, one of the most prominent strategies is to deal with an individual as a single entity, that is, a heterogeneous mixture of individuals. This is a feature of the Individual-Based Model (IBM) [16].Individual-Based model (IBM) has been used to analyze epidemiological mathematical models in a more realistically way. The IBM deals with many entities, spatial scales, heterogeneities, and stochastic events, it is necessarily more complex than classical models [17]. Thus, IBM’s purpose is to model infectious diseases in populations in which individuals can be divided into epidemiological states. This framework is intended as an alternative to replace or complement 
compartment models, such as SIR [5]. More recently, a considerable number of works have been developed to model and control disease around the world using IBM as a tool, strategies such as vaccination programs or isolation programs, such as School closure, are applied to mitigate the effects of a pandemic. Due to its excellent results, vaccination is still considered one of the most effective strategies to prevent infectious diseases and their consequences [18]. Most often, the IBM simulates experiments in a computational environment, considering individual characteristics and the environment in which they are, i.e. interactions between individuals [19]. The implementation of such models 
is already facilitated by software platforms specifically designed to implement models based on individuals [20,21]. Future perspectives for the IBM can be assembled from a tried and tested construction block toolkit representing, for example, energy budgeting, habitat selection, and feature composition [22]. In this paper, a review section investigates the frequency and methods of such applications in IBM. The 
focus of this survey is on IBM applied to infectious diseases 
in humans and their perspectives [23,24]. In this systematic review, we summarized and discussed IBM applications and terminology in different epidemiological disciplines, published between 1997 and 2017. The characteristics of the model were analyzed and discussed, such as the implementation of social mixtures, demographic evolution over time, modeling platforms for IBM’s, and such as strategies to contain an epidemic. In addition to the literature review, three simulation experiments will be presented. First, an example of IBM is described. Second, IBM is adjusted to have an average behavior corresponding to a SIR model. In the third experiment, the limitations of the models related to the effects of discretization and the generation of chaos are presented.
Material and Methods
Literature Review
A systematic review of studies using IBM applied to the transmission of infectious diseases in humans has been conducted. The strategy adopted for review research is to use IBM as the comprehensive term for individual-level models, also observed as agent-based model, cellular automata 
(CA), and so on. The definition based on the literature for 
Individual-Based Model is: “A computational tool capable of simulating individuals that interact with each other, where individuals or agents have unique attributes that change throughout the life cycle” [21,22].
Search: This is a literature review with search frequency from 1997 to the present. The search engines were SCOPUS, 
IEEE and WEB OF SCIENCE. Based on the listed definitions and exploratory searches, the following search query was 
used: “(“individual based model”) AND (biomedic* OR “infectious disease” OR epidem*)”. With date and descriptor restrictions, initially there were 226 articles in the Web of Science database, where the Topic search restriction was used meaning search by title, abstracts, and keywords in all databases. For the Scopus database, 233 studies were found by searching by title, abstracts and keywords in all databases. For the IEEE database, 673 studies were found in all databases. Original research papers were included using an IBM focused on the transmission of infectious diseases in humans. That is, reviews and studies related to animal research, ecology and molecular biology were excluded. 
All abstracts of these papers were read and evaluated 
for inclusion or exclusion in the present review. After the detailed reading of the abstracts, application of the inclusion and exclusion criteria, there were 31 papers in the Web of 
Science, 55 in Scopus and 20 in the IEEE. From a total of 
1132 studies, 106 papers were selected. After checking for 
some duplication, the final sample of the present review is composed of 88 articles. The search process is shown in Figure 1.
To the best of authors’ knowledge, we could not find a survey of IBM with focus on biomedical and epidemiological research. This is one of the main objectives of this paper. 
Additionally, as it has been already mentioned, we have provided some general mathematical description of the IBM 
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as well some concerns regarding the effects of discretization schemes, which are more usually investigated for differential equations, but they may also bring some inconsistent results for the IBM.
Model classification: The articles were classified in three broad areas of approach:
Topic: Type of pathogenesis.
•	 Disease: The disease addressed in Article;
•	 Type: Forms of contagion;
Modeling purpose: The proposal presented.
•	 Methods: Description of new approaches to IBM research, introducing modeling concepts, performance enhancements, simulation techniques, or mathematical techniques;
•	 Dynamics: Using methods to understand the dynamics of the transmission and elaborate on the best assumptions of the model a viable solution;
•	 Interventions: Evaluation intervention measures to inform policy makers and organizations, based on knowledge of the dynamics of transmission and economic analysis;
Control strategy: Intervention strategy used.
•	 Vaccination;
•	 Antivirals, drugs;
•	 Screening;
•	 Non-pharmaceutical intervention (NPI): social distancing, closure of schools, improvement of living standards and urban mobility.
Full-text trace: To extract features and applications from the model, a full-text exam was done for the selected articles as a function of the human application on infectious diseases. 
Some studies have been found in this context on Influenza, 
Hepatitis A, Hepatitis B, Hepatitis C, HIV, HPV, Measles, 
Polio, Ebola, Smallpox, Chickenpox, SARS, Respiratory Syncytial Virus, Tuberculosis, Bubonic Plague, Pertussis, Lepra, Gonorrhea, Chagas Disease, Schistosoma, Dengue, Chikungunya, Malaria and Varicella Zoster. For each full-text article, we list the topic, the purpose of modeling and control strategy that have been used, employing IBM as a tool.
Bibliometric indicators: Table 1 presents schematically the results found giving an overview of the different themes, modeling purposes and study characteristics. The result of the review consists of 86 articles and the years of publication ranged from 1997 to 2018. The Search Process was explained in Section 2.1.1. during the selection of the articles it was possible to observe a change in the applications used 
Number  of articles identified: 1132
IEEE: 673
Web of Science: 226
Scopur: 233
.
.
.
Number of articles excluded after
reading the abstracts and applying the 
exclusion criteria: 1026
Selected studies for evaluation: 106
Number of discarding duplicates: 18
Final Sample: 88
Figure 1: Search process and collection of articles. 
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in IBM, which explains the selection of more recent works, this change occurred from studies focused on methodology papers for applications and purposes related to intervention. 
Methodological papers, not applied to a specified close-contact infection, mostly describe the conceptual usage of an 
IBM to simulate heterogeneous disease dynamics. Among the 
selected papers, 2015 has the largest number of publications 
(17), one can consider this fact in front of the Ebola in 2015 
[25-30]. From 1997 to 2003, no publication was found from the delineated search process.Most papers in our selection are on HIV - human 
immunodeficiency virus (15.90%), closely followed by 
influenza (14.77%). Articles about influenza, according to the selection, use vaccination, isolation or school closure 
programs to control seasonal or pandemic influenza 
outbreaks [31-43]. On the other hand, the majority of the works of general close-contact diseases were written with the intention of describing the transmission dynamics or the 
methodology of mathematical models [44-53]. As previously mentioned, the applications of the IBM have migrated to a certain extent, from the use of methodological works for applications aimed at the intervention of infectious diseases. This is observed in the number of works related to human 
immunodeficiency (HIV) or sexual transmission [54-69], 
tuberculosis [70-75], dengue [76-80], Hepatitis C [81-86] 
and Ebola [25-30] in this review.
For vector-borne disease models, Dengue is the most studied subject. Generally, the studies try to understand the pathogenicity, transmission dynamics and even to create computational tools for the prevention and control of Dengue. Some papers have used computer platforms 
using mathematical software such as MATLAB [40,65]. In 
addition, software’s such as NetLogo [52,74], AnyLogic [82], 
DengueME [78,79], HexSim [87] and NOVA [29] were used as explicit modeling platforms (Table 1). Works published with IBM focused on infectious diseases are in constant ascendancy. In this review, most of the 
articles included were on topics focused on HIV, influenza or 
unspecified Close-contact, but this does not restrict studies on IBM. Studies of diseases transmitted by vectors, parasites 
[88,89] or bacteria [90-95] are also being approached and with a perspective of increasing work for the next years. Vector-borne diseases such as dengue [76-80], malaria [96,97] and chikungunya [98] are being improved, given the increasing geographic expansion of their vectors, generating future research perspectives.Many papers use socioeconomic and biomedical databases to make predictions with mathematical models, along with interventions such as isolation and vaccination, to predict pandemic outbreaks, taking health care into account, and 
informing authorities of efficiency and efforts to end the 
Topic
Count
Modeling Purpose Control Strategy
Disease Type Methods Dynamics Interventions Vaccine NPI Drugs Screening
Unspecified Close-contact General 11 9 6 2 1 10 - -
Unspecified STI General 1 - 1 - - 1 - -
Chickenpox Viral 1 - - 1 - 1 - -
Ebola Viral 6 4 4 2 1 6 1 -
Hepatitis A Viral 1 - - 1 1 1 - -
Hepatitis B Viral 1 1 - - - 1 - -
Hepatitis C Viral 6 3 - 4 1 4 1 1
HIV Viral 14 5 4 7 - 13 1 3
HIV+Hepatitis C Viral 1 - 1 - - - 1 -
HPV Viral 3 - 2 1 3 - - 1
Influenza Viral 13 8 3 6 2 10 2 -
Measles Viral 1 1 1 - 1 - - -
Polio Viral 2 2 - - 2 - - -
Respiratory syncytial virus Viral 1 - - 1 1 - - -
SARS Viral 1 1 - - - 1 - -
Smallpox Viral 2 - - 2 2 2 - -
Varicella Zoster Viral 1 1 - - 1 - - -
Bubonic plague Bacterial 1 - 1 - - 1 - -
Gonorrhea Bacterial 1 1 - - - 1 - -
Lepra Bacterial 3 - 1 3 - 1 2 -
Pertussis Bacterial 1 1 - 1 1 - - -
Tuberculose Bacterial 6 2 3 1 - 5 - -
Chagas disease Parasitic 1 - 1 - - 1 - -
Schistosoma Parasitic 1 1 1 - - 1 - -
Chikungunya Vector-borne 1 - 1 - - 1 - -
Dengue Vector-borne 5 3 5 - 1 4 - -
Malaria Vector-borne 2 - 1 1 - 2 - -
TOTAL 88 43 36 33 18 67 8 5
Table 1: Characteristics of IBM studies applied to humans in the transmission of infectious diseases published from 1997 to 2018. Intervention studies may also 
describe dynamics and methods, as some papers may describe more than one strategy. HIV: human immunodeficiency virus, HPV: human papillomavirus, STI: 
sexually transmitted infection, SARS: Severe acute respiratory syndrome.
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pandemic. Few studies have been found on Chickenpox 
[99], Varicella [100], Hepatitis A [101], Hepatitis B [102], 
HPV [103-105], Measles [106], Polio [107,108], Respiratory 
Virus [109], SARS [110] and Smallpox [111,112], which do not mean that these pathogens are not being studied by other researchers because their socioeconomic aspects are extreme importance. Future research, using IBM, should address these and other topics more frequently, bringing 
some aspects that can influence the spread of diseases such as social awareness, climate change and global mobility.
Mathematical models
Compartment models: The SIR model (Susceptible-Infected-Recovered) is a compartmental model formulated in terms of differential equations, to study the consequences of a contagious disease that spreads rapidly in a population. The three compartments considered are:
•	Susceptible: individuals who are not infected but may come to be.
•	Infected: individuals who are with the disease and are able to pass it on to other individuals.
•	Recovered: individuals who are recovered and immune to contagion. Immunity in this case consists of an individual with permanent immunity acquired by the infection.There are other derivations of the SIR model presented to describe infectious diseases, following the same rationale. In order to obtain the set of equations that represent the SIR model, some considerations are made:
 Individuals are homogeneously distributed within a population.
 The population is considered constant, d = µ.
 The number of individuals in the infected compartment increases at a rate that is proportional to the number of individuals in the infecting class and to the number of individuals in the susceptible compartment, mathematically represented by the portion β(S)I(t).
 The rate at which infected individuals are transferred into the class of the recovered is proportional to the number of infected. This fact is modeled by γI(t). Thus, at an instant of time t a population is characterized by:
( ) ( ) ( )N S t I t R t= + +                                                                  (1)  Where, N is the total number of individuals in a population at instant t. Therefore, the SIR model can be written as the set of differential equations:                                                              ( )
( )
( )
  ,            0 0,
  ,             0 0,
  ,             0 0,
dS IS
µN µS S S
dt N
dI IS
I µI I I
dt N
dR I µR R R
dt
= − − = ≥
= − − = ≥
= − = ≥
                                                 (2)
It is often set s(t) = S(t) = N, i(t) = I(t) = N and r(t) = R(t) = N, 
as being, respectively, the proportion of susceptible, infected and recovered in a population of constant size N. β is the infection rate, µ is the death rate and γ is the recovered rate. Dividing the equations into (2) by N:
     0
0
,         0
,  0.
ds µ µs is s
dt
di is i µi i
dt
β
β γ
= − − ≥
= − − ≥
                                          (3) 
In this way, the population size is normalized, that is, N = 1, and the class of recovered can be determined by: r(t) = 1-s(t)-
i(t) 
The fixed points of the Equations in (3) are obtained from:
( )
( )
, 0
, 0
ds f s i
dt
di g s i
dt
= =
= =
                             (4)
 Through Equation (4), the following fixed points are obtained for the SIR model:
( ) ( )
( )
1 1 1
2 2 2
, 0,1
, ,
f f
f f
P s i
µ µ µP s i
µ
γ
β γ β
=
 +
= − + 
                                         (5)
The analysis of the dynamics of the SIR model given by [2], allows two states of equilibrium (P1 and P2) to determine. The 
fixed point (P1), the population is free of infection and the 
fixed point P2, the population of infected goes to an endemic balance. Endemic diseases are the result of long-term equilibrium between agent and host. There is a concern to adapt the parameters of the SIR model, so that the prediction of the evolution of the epidemic and simulation of the spread of the disease are satisfactory, due to the many uncertainties in the problem.
Applying the forward Euler scheme to model (3) can be obtained the following discrete-time SIR epidemic model
( )
( )
1  
1
,
.
n n n n n
n n n n n n
S S h µ µS S I
I I h I S I µI
β
β γ
+
+
= + − −
= + − −
                                                         (6)where h is the step size, µ, β and γ are defined as model (2).
Individual-Based Model (IBM): IBM’s are important for both theory and application, because they allow researchers to consider aspects generally overlooked in analytical models such as, interaction between individuals, local interactions, complete life cycles, and so on. However, they have their weaknesses, the IBMs have their structure more complex 
than compartmental models, so they are more difficult to implement, analyze and understand. For this reason, Grimm and colleagues have developed a standard protocol for describing IBM. The protocol is composed of three blocks: overview, design concepts and details. The Overview block provides the general purpose and structure of the model. The Design concept block describes the general concepts underlying the design of the model. Finally, the Details block displays information that was omitted from the overview, 
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such as initialization, input, and sub models. Background information in the ODD protocol can be obtained from 
[19,24]. An IBM allows to emulate simulation experiences in a computational environment taking into account the characteristics and interaction of each individual. In this way, aspects that are generally ignored by other models can be considered making the system more realistic. The purpose of IBM is to model infectious diseases, for this work is considered an equivalence between IBM and SIR, therefore IBM complements the SIR model, considering also those individuals can be divided into epidemiological states.In the mathematical formulation considered for the IBM, the individual can be represented by
, ,1, ,2, , ,   ,n t n t n t n m tI C C C = …                                                   (7)where n  is a sequential number that identifies an individual, m is the number of features, t is the instant that 
the individual presents a specific set of characteristics and Cn,m,t is a characteristic considered for the individual. The 
first characteristic is its epidemiological status, which may be susceptible, infected, recovered. Other characteristics may be age, duration of infection, sex, spatial location or any other characteristics of the individual considered relevant. It is important to highlight that the characteristics Cn,m,t in 
(7) may change with time. A collection of individuals can be represented as a population:
1, 2, 3, ,   ,
T
t t t t m tP I I I I = …                                                        (8)where Im,t is an individual at time t and   m x nP∈  is a matrix. Probabilistic distributions are used for an individual to 
verify when a state transition occurs. After the Im,t individuals 
are evaluated, the simulation time is incremented by ∆t. This formulation of the model is quite generic, allowing to incorporate several characteristics of the individuals. The employed model has the following characteristics:
•	C1∈[0,1,2]. That is, the individual may be in the susceptible, infected and retrieved state respectively.
•	C2 is the age of an individual, which receives an addition of 
∆t in each transition time.
•	C3 is the maximum age at which the individual will live. 
At the moment of the birth of the individual this value is obtained by:
( )3 uC µlog a= −                                                                                (9)where µ is the life expectancy of the population and au is a random variance with uniform distribution, contained between 0 and 1.
•	C
4 
is the time that the individual is in the infecting state.
•	C
5
 is the maximum time the individual is in the infecting state. Like the C3 characteristic, the maximum time the individual becomes infected is obtained a priori by:
( )5 uC log aγ= −                                                                            (10)where γ is the infecting period.Susceptible and recovered individuals do not present 
characteristics C
4
 and C
5
. In this case they are zero. The number of susceptible, infected and recovered individuals at each instant t of the population is denoted by St, It and Rt, respectively. Figure 2 shows an IBM flowchart. The characteristics of the initial population are determined randomly, given the probability distributions of the state variables. 
ResultsThis section presents the results of simulations experiments of IBM and SIR model.
Developing an IBM for infectious diseases: In order to show how IBM works and how it can be used as an alternative to the SIR model let us consider a hypothetical disease. Figure 3 shows IBM used to simulate a hypothetical disease that exhibits three epidemiological states: susceptible, infected and recovered. The parameters that have been used 
are Δt = 0.1, γ = 1/3, µ = 1/60, α = 1/60 and β = 0.25. The initial conditions are N (0) = 1000, S (0) = 900, I (0) = 10, and R (0) = 90. Figure 3 presents the results obtained from the IBM simulation. One can see that infected individuals tend to zero, which means that the epidemic tends to be eradicated. For this set of dynamic parameters IBM was simulated only once (Figure 3). The same dynamic parameters have been considered to 
simulate the discretized SIR model. Figure 4 shows this result. It is possible to observe that the same behavior that 
 
Initial Parameters
Initial Population
t = 0
t=t+  t Yes
Endt > tf
No
Individuals die if
P(:,2) > P(:,3)
New Individuals born Transition to 0
Individuals recover if
P(:,4) > P(:,5) Transition to 2
Individual n=1
Yes n=n+1
n >N(t)
No
Yes No
Susceptible Infection
Yes
Transition to 1
No
Figure 2. Flowchart of IBM for an epidemiological system, which presents 
three classes: susceptible, infected and recovered. Source: [5].
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Figure 3. Simulation of IBM, showing Susceptible, Infected and Recovered individuals. Δt = 0.1, γ = 1/3, µ = 1/60, α = 1/60 and β = 0.25. The initial conditions 
are N (0) = 1000, S (0) = 900, I (0) = 10, and R (0) = 90. 
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Figure 4: Simulation of SIR model, showing Susceptible, Infected and Recovered individuals. Δt = 0.1, γ = 1/3, µ = 1/60, α = 1/60 and β = 0.25. The initial 
conditions are N (0) = 1000, S (0) = 900, I (0) = 10, and R (0) = 90. 
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have been seen in Figure 3 for IBM, occurs for this model, noting that infected individuals tend to zero, the epidemic 
tends to end (Figure 4). Next step is check for equivalence between the SIR model and IBM. To consolidate this result the Monte Carlo method have been used, where the IBM was simulated 100 times. 
Figure 5 depicts the Monte Carlo simulation for IBM, we notice a jump at t  = 230, this is due to the stochasticity of the 
model (Figure 5). To validate the equivalence between the SIR and IBM models the mean and standard deviation were calculated for each time value, as shown in Figure 6. It is possible to notice that IBM presents an average behavior that approaches the SIR model, represented in red. In this plot, it is presented only the number of infected individuals. Similar results are obtained for susceptible and recovered individuals.It is important to show that by changing the integration step of the IBM model it loses stability, Figures 7-9 shows the simulated IBM model with the following parameters γ = 
1/3, µ = 1/60, α = 1/60 and β = 0.25. The initial conditions are, N (0) = 1000, S (0) = 900, I (0) = 10, and R (0) = 90. The 
integration steps used for the simulations were Δt = 0.1, Δt = 
0.5 and Δt = 1 (Figure 6-9).
For integration steps of Δt = 0.5 and Δt = 1, the IBM loses stability. The dynamic behavior of the model changes. The same behavior can be observed for compartmental models, for this case the discrete SIR model is studied, because its 
dynamic behavior is very plentiful and more complex than model SIR in continuous time [7]. That said, Figure 10 shows the bifurcation diagram for the SIR model. The following parameters for the discrete SIR were used µ = 0,2 γ = 0.15 
and β = 0.12 The initial conditions were S (0) = 8 and I (0) = 
5. These parameters were taken from [7]. As h varies a Flip bifurcation occurs, so it is easy to notice that there is chaos for this range of values (Figure 10). 
ConclusionThis article presented a literature review along with simulations of the SIR and IBM models for epidemiological systems. In the literature review, the selected papers were 
mostly on applications of diseases in humans. A total of 86 papers were selected, most of which addressed IBM applications on infectious diseases in humans. Some papers provided solutions for modeling and application of methods to prevent and control diseases using IBM as a computational tool. Examples using IBM have been shown in this paper, where the approach used of IBM allowed 
to consider specific characteristics of the individuals, considering them heterogeneous. The focus of this work was the analysis of phenomena associated with the models, both for continuous and discretized compartmental models and for stochastic models such as IBM. For IBM, some simulation experiments were tested, where the epidemiological system presents three classes: susceptible, infected and recovered. The population is considered constant and, at some point, integration steps are changed. The results show that IBM 
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Figure 5: Monte Carlo simulation (100 runs). The parameters used Δt = 0.1, γ = 1/3, µ = 1/60, α = 1/60 and β = 0.25. The initial conditions are N (0) = 1000, 
S (0) = 900, I (0) = 10, and R (0) = 90. and R (0) = 90. 
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Figure 6: Monte Carlo simulation of IBM, showing average and standard deviation of Infected individual. In red individuals infected with the SIR model. The 
parameters used Δt = 0.1, γ = 1/3, µ = 1/60, α = 1/60 and β = 0.25.  The initial conditions are N (0) = 1000, S (0) = 900, I (0) = 10, and R (0) = 90.
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Figure 7: Simulation of IBM with integration step Δt = 0.1.can model an epidemic leading to eradication, however, the model shows a loss of stability when the integration 
step is changed. A similar phenomenon occurs for the 
discrete SIR model, where for a specific set of values the model presents chaotic characteristics, which can be observed through the Bifurcation diagram. To consolidate 
these results it was necessary to prove the equivalence between the models, where IBM has an average behavior that approaches the SIR model. In addition, the number of infected individuals reaches an endemic value, which is expected for this simulation. Therefore, is important to note that, like deterministic models, stochastic models also have 
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Figure 8: Simulation of IBM with integration step Δt = 0.5.
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Figure 9: Simulation of IBM with integration step Δt = 0.1.
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Figure 10: Discrete SIR model. The Flip bifurcation of I (n) with A = µ × N = 4, with µ = 0.2, γ = 0.15 and β = 0.12. h ϵ [2, 2.85] and initial values (S0, I0) = 
(8, 5). Source: [7].physical and structural limitations, i.e., chaos and loss of stability, leaving researchers alert to the use of these models even if they present reasonable results. Future directions of the IBM research on infectious diseases should be focused on the development of techniques to combat epidemics. In terms of application, the results presented here suggest that simulations using mathematical models, especially IBM, may be useful for evaluating methodologies for the eradication of several types of epidemics, however their limitations must be considered.
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